Navigation Links
CVS Caremark to Offer Medical Benefit Drug Management Services to Clients
Date:4/14/2011

WOONSOCKET, R.I., April 14, 2011 /PRNewswire/ -- CVS Caremark Corporation (NYSE: CVS) today announced a new medical benefit drug management service for the company's pharmacy benefit management (PBM) and specialty pharmacy clients.  The offering is the first of its kind to provide a comprehensive management solution for the buy-and-bill drug model currently used by physicians (whereby the physician purchases specialty medications, administers them to the patient and directly bills the payer).  The payer-centric offering will employ both prospective and retrospective drug utilization management strategies to drugs billed under the medical benefit, while ensuring minimal disruption to the physician's workflow and facilitating the delivery of evidence-based care.  CVS Caremark will work with New Century Health, a specialty care management company, to offer its clients integrated evidence-based medicine, treatment care pathways, quality improvement programs, and peer-to-peer review through an innovative web-based decision support platform.  This offering will be broadly available to CVS Caremark customers for implementation beginning January 1, 2012.

(Logo: http://photos.prnewswire.com/prnh/20090226/NE75914LOGO)

Management of specialty drugs under the medical benefit poses a significant challenge to health plans and employers today.  In fact, more than 50 percent of specialty drugs are billed under the medical benefit, many of which are administered in a physician's office.  Payers are less able to identify and apply effective clinical and cost management strategies, similar to those applied to specialty drugs billed under the pharmacy benefit, due to current medical claims, processing limitations and limited visibility to its clinical applications.  Through analysis of CVS Caremark data, it was found that among the company's PBM clients, cancer and associated supportive care specialty drugs -- such as hematopoietics for anemia and neutropenia -- account for approximately 53 percent of the total specialty drug spend billed to the medical benefit. As a result, CVS Caremark's new offering will initially focus on improving the quality, safety, and management of oncology drugs billed under the medical benefit. Estimated savings of up to 15 percent of a payer's oncology spend are expected.

"This offering will enable CVS Caremark to identify the unrecognized specialty pharmacy spend currently billed through the medical benefit for oncology patients," said Per Lofberg, President of CVS Caremark's pharmacy benefit management business. "By systematically tracking and analyzing this activity, we can provide our clients with an opportunity to better manage these expensive drugs while also improving the quality of care for their members."

About CVS Caremark

CVS Caremark is the largest pharmacy care provider in the United States with integrated offerings across the entire spectrum of pharmacy care.  We are uniquely positioned to engage plan members in behaviors that improve their health and to lower overall health care costs for health plans, plan sponsors and their members. CVS Caremark is a market leader in mail order pharmacy, retail pharmacy, specialty pharmacy, and retail clinics, and is a leading provider of Medicare Part D Prescription Drug Plans. As one of the country's largest pharmacy benefits managers (PBMs), we provide access to a network of approximately 65,000 pharmacies, including more than 7,100 CVS/pharmacy® stores that provide unparalleled service and capabilities. Our clinical offerings include our signature Pharmacy Advisor™ program as well as innovative generic step therapy and genetic benefit management programs that promote more cost effective and healthier behaviors and improve health care outcomes. General information about CVS Caremark is available through the Company's Web site at http://info.cvscaremark.com/.

About New Century Health

Headquartered in Brea, California with operations in Florida, Ohio, and Indiana, New Century Health delivers specialty care management solutions that leverage technology and evidence-based medicine at the point-of-care, with a focus on oncology and cardiology.  Our services promote the most effective treatment, reduce variability, improve clinical outcomes, and optimize cost-effectiveness. Our vision is to lead the specialty care management industry by harnessing the knowledge, technology, and innovation that power a higher quality of care and life.  The customers of New Century Health include both payers and providers working in all lines of business (including Medicare and Medicaid). New Century is a company of Water Street Healthcare Partners, a strategic private equity firm focused exclusively on health care.  To learn more about New Century Health, visit www.NewCenturyHealth.com.

Contacts:
Christine Cramer
Corporate Communications
CVS Caremark
401-770-3317
ckcramer@cvs.com

Sid Stolz
New Century Health
214-477-3261
sstolz@newcenturyhealth.com


'/>"/>
SOURCE CVS Caremark
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. CVS Caremark Insights 2011 Report Highlights Lowest Drug Trend in Six Years and Increased Utilization of Generics
2. CVS Caremark Named One of Americas Most Reputable Companies by Reputation Institute
3. CVS Caremark Research Finds "Dispense as Written" Prescriptions May Add $7.7 Billion to Annual Health Care Costs
4. CVS Caremark Charitable Trust Makes Initial Donation of $100,000 to Relief Effort in Japan
5. CVS Caremark Announces Agreement With ActiveHealth Management for Evidence-Based Clinical Decision Support
6. CVS Caremark and Universal American Announce Termination of Hart-Scott-Rodino Waiting Period
7. CVS Caremark Awarded Pharmacy Benefit Management Institute Rx Benefit Innovation Award for Pharmacy Advisor Program
8. CVS Caremark Corporation to Hold Fourth Quarter 2010 Conference Call
9. CVS Caremark Study Evaluates Which Pharmacy Channel Consumers Choose When Given Choice of Mail or Retail Prescriptions
10. CVS Caremark Announces Interim Leadership for Retail Business
11. CVS Caremark Study Finds Patients with Complex Therapies Struggle to Stay Adherent to their Medications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... April 20, 2017  Cogentix Medical, Inc. (NASDAQ: ... providing the Urology, Uro/Gyn and Gynecology markets with ... Keswani has joined the Company as Senior Vice ... created position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has ...
(Date:4/20/2017)... 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), ... address significant unmet medical needs, today announced that ... consumer product development program, based on its proprietary ... Investigative Dermatology (SID) 76 th Annual Meeting.  ... the sciences relevant to skin health and disease ...
(Date:4/20/2017)... -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, today ... C virus (HCV) infected patients with genotype 1, ... (Child-Pugh A) achieved sustained virologic response at 12 ... pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high SVR ... of G/P treatment without ribavirin. Patients with specific ...
Breaking Medicine Technology:
(Date:4/24/2017)... Boca Raton, Florida (PRWEB) , ... April 24, 2017 , ... ... natural chai teas, announced its products are now available for purchase on RevNutrition.com, a ... ancient form of tea first produced and popularized in ancient India and Siam. It ...
(Date:4/24/2017)... , ... April 24, 2017 , ... ... healthcare compliance and credentialing solutions, today announced that Kyle Allain has joined the ... Cactus Provider Management sales and operations, including provider, payor and managed care solutions. ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... to be diagnosed globally; approximately 25,000 of them will be malignant.(1) As research ... of this type of healthcare model in the diagnosis and treatment of brain ...
(Date:4/24/2017)... IL (PRWEB) , ... April 24, 2017 , ... Rod ... the Senior Housing News website. , Rod has been at the forefront of Gardant ... company’s culture. As CEO, Rod has overseen the opening of more than 40 new ...
(Date:4/24/2017)... ... April 24, 2017 , ... As a former supermodel known for ... The good news for single women is that she put all the words in ... April 25th. Joan's insight, personal experiences and sparkling sense of humor have inspired her ...
Breaking Medicine News(10 mins):